-+ 0.00%
-+ 0.00%
-+ 0.00%

Tenax Therapeutics Q4 EPS $(0.38) Beats $(0.41) Estimate

Benzinga·03/10/2026 11:18:53
Listen to the news
Tenax Therapeutics (NASDAQ:TENX) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $(0.41) by 7.32 percent. This is a 111.11 percent decrease over losses of $(0.18) per share from the same period last year.